Chapter 7- Venous Thromboembolism

Description:
IMPORTANT NOTE – PLEASE READ FIRST: This continuing education assessment requires that you first purchase the text book: Pharmacotherapy Principles & Practice. Please go to our home page: http://www.rxugace.com/ and click on “Books” for more information Prior To Registering for this assessment.

Upon completion of the corresponding textbook chapter in Pharmacotherapy Principles & Practice and this on-line assessment, the reader should be able to:
1. Identify risk factors and signs and symptoms of deep vein thrombosis and pulmonary embolism.
2. Describe the processes of hemostasis and thrombosis, including the role of the vascular endothelium, platelets, coagulation cascade, and thrombolytic proteins.
3. Determine a patient’s relative risk (low, moderate, high, or very high) of developing venous thrombosis.
4. State at least two potential advantages of the low-molecular-weight heparins and fondaparinux over unfractionated heparin.
5. Formulate an appropriate prevention strategy for a patient at risk for deep vein thrombosis
6. Identify factors that place a patient at high risk of bleeding while receiving antithrombotic drugs.
7. Select and interpret laboratory test(s) to monitor antithrombotic drugs.
8. Identify and analyze warfarin drug-drug and drug-food interactions.
9. Manage a patient with an elevated International Normalized Ratio (INR) with or without bleeding.
10. Formulate an appropriate treatment plan for a patient who develops a deep vein thrombosis or pulmonary embolism, and develop a comprehensive education plan for a patient who is receiving an antithrombotic drug.

Courses Offered